Quantum Genomics Quantum Genomics
  • Company
    • Management
    • Board of directors
    • Inventors
    • Scientific and clinical advisory board
  • Science
    • The BAPAIs
  • Investors
    • Press releases
    • Financial documents
      • Annual information
      • Semi-annual information
      • Other regulated informations
    • Shareholder letter
    • General meetings
    • Shareholding
    • Financial calendar
    • Contacts
  • Contact us
  • Français

News

Testimony of Denis, shareholder since 2016 (in French)

Testimony of Denis, shareholder since 2016 (in French) See the video  

27 July 2021
Quantum 2021-07-27T17:30:11+02:00
News

First patient enrolled in REFREH study

First patient enrolled in REFREH study Read the press realease 

8 July 2021
Quantum 2021-07-08T08:20:30+02:00
News

August 28th: Presentation of the Effects of QGC606 in an Experimental Model of Heart Failure

August 28th: Presentation of the Effects of QGC606 in an Experimental Model of Heart Failure…

5 July 2021
Quantum 2021-07-05T08:31:30+02:00
News

Exclusive interview with Professor Gilles Montalescot

Exclusive interview with Professor Gilles Montalescot See the video

29 June 2021
Quantum 2021-06-29T18:38:58+02:00
News

QUORUM study: Results Announcement next August 27, 2021 at 10:30 am CEST

QUORUM study: Results Announcement next August 27, 2021 at 10:30 am CEST Read the press…

29 June 2021
Quantum 2021-06-29T17:28:11+02:00
News

Quantum Genomics Secures €3 Million Non-dilutive Financing

Quantum Genomics Secures €3 Million Non-dilutive Financing Read the press realease

28 April 2021
Quantum 2021-04-28T18:23:34+02:00
News

Quantum Genomics will Present Top-line Results from its QUORUM study at European Society of Cardiology (ESC) Meeting

Quantum Genomics will Present Top-line Results from its QUORUM study European Society of Cardiology (ESC)…

21 April 2021
Quantum 2021-04-21T08:04:31+02:00
News

Quantum Genomics Reports Full Year 2020 Operating and Financial Results

Quantum Genomics Reports Full Year 2020 Operating and Financial Results Read the press realease

25 March 2021
Quantum 2021-03-25T18:21:48+01:00
News

Orient EuroPharma (OEP) acquires a stake in Quantum Genomics

As a follow-up to the agreement signed last September, OEP acquired a minority stake in…

9 February 2021
Quantum 2021-02-09T18:09:39+01:00
News

Quantum Genomics launches Phase III Pivotal REFRESH Study in Difficult-to-treat/Resistant Hypertension

Quantum Genomics launches Phase III Pivotal REFRESH Study in Difficult-to-treat/Resistant Hypertension Read the press realease

18 January 2021
Quantum 2021-01-18T08:11:57+01:00
Information
  • Blog
  • Home
  • Contact us
About

Quantum Genomics is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially high blood pressure and heart failure.

Contact us

33 rue Marbeuf
75008 Paris

[email protected]
+33(0)1 85 34 77 70

Write us

Quick access
  • Strategy
  • Pipeline
  • Did you know that ?
  • Scientific Publications
Search

 

© 2019 Quantum Genomics - Legal notice - Website terms and conditions

  • Company
    • Management
    • Board of directors
    • Inventors
    • Scientific and clinical advisory board
  • Science
    • The BAPAIs
  • Investors
    • Press releases
    • Financial documents
      • Annual information
      • Semi-annual information
      • Other regulated informations
    • Shareholder letter
    • General meetings
    • Shareholding
    • Financial calendar
    • Contacts
  • Contact us
  • Français
  • Blog
  • Home
  • Contact us